68 related articles for article (PubMed ID: 18954725)
21. Is protracted low-dose temozolomide feasible in glioma patients?
Wong ET
Neurology; 2006 Aug; 67(3):543-4; author reply 543-4. PubMed ID: 16894133
[No Abstract] [Full Text] [Related]
22. Current and future developments in the use of temozolomide for the treatment of brain tumours.
Stupp R; Gander M; Leyvraz S; Newlands E
Lancet Oncol; 2001 Sep; 2(9):552-60. PubMed ID: 11905710
[TBL] [Abstract][Full Text] [Related]
23. The inhibition of proliferation and migration of glioma spheroids exposed to temozolomide is less than additive if combined with irradiation.
Fehlauer F; Muench M; Richter E; Rades D
Oncol Rep; 2007 Apr; 17(4):941-5. PubMed ID: 17342340
[TBL] [Abstract][Full Text] [Related]
24. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
[TBL] [Abstract][Full Text] [Related]
25. Temozolomide for malignant brain tumours.
Batchelor T
Lancet; 2000 Apr; 355(9210):1115-6. PubMed ID: 10791369
[No Abstract] [Full Text] [Related]
26. Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation.
Schiff D
Cancer Invest; 2007 Dec; 25(8):776-84. PubMed ID: 17952745
[TBL] [Abstract][Full Text] [Related]
27. Effects of temozolomide in malignant brain tumours.
Osoba D
Lancet; 2000 Jul; 356(9226):342. PubMed ID: 11071219
[No Abstract] [Full Text] [Related]
28. Adding concomitant and adjuvant temozolomide to radiotherapy does not reduce health-related quality of life in people with glioblastoma.
Hamilton DA
Cancer Treat Rev; 2006 Oct; 32(6):483-6. PubMed ID: 16730911
[No Abstract] [Full Text] [Related]
29. Optimal treatment for intracranial germinoma: can we lower, radiation dose without chemotherapy? In regard to Yen S-H et al. (Int J Radiat Oncol Biol Phys Epub October 27, 2009).
Lavey RS; Olch AJ
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):638-9; author reply 639. PubMed ID: 20457356
[No Abstract] [Full Text] [Related]
30. Discrimination between glioma recurrence and radiation-induced necrosis: in regards to Qing-Shi et al. (Int J Radiat Oncol Biol Phys 2007;68:151-158).
Alexiou GA; Tsiouris S; Kyritsis AP; Polyzoidis KS; Fotopoulos AD
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1585-6; author reply 1586. PubMed ID: 17674998
[No Abstract] [Full Text] [Related]
31. Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol: in regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860).
Vordermark D; Kölbl O
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):296-7; author reply 297. PubMed ID: 15850943
[No Abstract] [Full Text] [Related]
32. Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitis.
Friedman HS
Semin Oncol; 2000 Jun; 27(3 Suppl 6):35-40. PubMed ID: 10866348
[TBL] [Abstract][Full Text] [Related]
33. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
[TBL] [Abstract][Full Text] [Related]
34. In regard to Chen et Al. (Int J Radiat Oncol Biol Phys 2007;69:25-31) and Chao et Al. (Int j Radiat Oncol Biol Phys 2007;69:32-40).
Yaeger TE
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):317; author reply 317-8. PubMed ID: 18406902
[No Abstract] [Full Text] [Related]
35. Temozolomide: too early for definitive conclusions.
Brown P; Buckner J
J Clin Oncol; 2003 Oct; 21(19):3710. PubMed ID: 14512412
[No Abstract] [Full Text] [Related]
36. Adjuvant whole brain radiotherapy: strong emotions decide but rationale studies are needed: in regard to Brown et al. (Int J Radiat Oncol Biol Phys 2008;70:1305-1309).
Larson D; Sahgal A
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):959. PubMed ID: 19014787
[No Abstract] [Full Text] [Related]
37. Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without previous gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas: in regard to Noel et al. (Int J Radiat Oncol Biol Phys 2011; DOI: 10.1016/j.ijrobp.2010.11.073).
Dixit S; Hingorani M; Achawal S; Scott I
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1593. PubMed ID: 22115561
[No Abstract] [Full Text] [Related]
38. Activation patterns of epidermal growth factor-receptor signaling in glioblastoma multiforme: in regard to Chakravarti et al. (Int J Radiat Oncol Biol Phys 2005;62:318-327).
Altundag K; Altundag O; Gunduz E; Boruban C
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1253; author reply 1253. PubMed ID: 15990031
[No Abstract] [Full Text] [Related]
39. Unplanned interruptions: unresolved issues: in regard to Bese et al. (Int J Radiat Oncol Biol Phys 2007;68:654-661).
Agarwal JP; Budrukkar A; Laskar SG
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1335-6; author reply 1336. PubMed ID: 17967327
[No Abstract] [Full Text] [Related]
40. Zoledronic acid sensitizes tumor cells to radiation: in response to Algur et al. (Int J Radiat Oncol Biol Phys 2005;61:535-542).
Ural AU; Avcu F
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):970. PubMed ID: 16199329
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
